Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. (Q40481231)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. |
scientific article |
Statements
1 reference
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia. (English)
1 reference
1 reference
Marco Montillo
1 reference
Alessandra Tedeschi
1 reference
Sara Miqueleiz
1 reference
Roberto Cairoli
1 reference
Liliana Intropido
1 reference
Francesca Ricci
1 reference
Anna Colosimo
1 reference
Barbara Scarpati
1 reference
Michela Montagna
1 reference
Michele Nichelatti
1 reference
Mario Regazzi
1 reference
Enrica Morra
1 reference
17 April 2006
1 reference
1 reference
24
1 reference
15
1 reference
2337-2342
1 reference
Identifiers
1 reference
1 reference